At its shareholders’ meeting on the 4th, Sofiva Genomics’ Chairwoman Yi-Ning Su stated that the company will concentrate on eight major operational goals, deepening its dual core technologies in maternal-fetal medicine and precision oncology, while actively pursuing new opportunities in the cancer screening market and expanding its presence across the Asia-Pacific region.
Last year, Sofiva Genomics reported revenue of NT$453 million, a slight decrease of 2.89% compared to the previous year. However, benefiting from improved operational efficiency and optimized product mix, its net profit after tax reached NT$19.12 million, marking a 60.43% year-on-year increase. Earnings per share (EPS) rose approximately 59% to NT$0.86, demonstrating solid management strength.
Yi-Ning Su emphasized that the company will continue its established genetic testing services and officially enter the cancer screening market in 2025 by introducing ctDNA genetic testing technology supported by evidence published in the internationally renowned New England Journal of Medicine (NEJM). This technology enables early cancer detection through a simple blood draw, aiming to fulfill the medical vision of “early detection, early treatment.” Initially, the service will be prioritized at the group’s own Herxin Health Management Centers, combining genetic counseling and clinical resources to provide precise testing and report interpretation.
Sofiva has currently established six major product lines, including genetic testing services in reproductive medicine, prenatal and pre-pregnancy care, newborn screening, cancer, precision medication, and rare diseases. This year, the company will focus on eight operational goals: strengthening customer-oriented services, multi-channel expansion, digital transformation, cross-group collaboration, advancing precision medicine, building comprehensive service systems, and actively expanding into international markets such as Thailand and Japan, aiming to become a leading genomic medicine laboratory in the Asia-Pacific region.
Resource: 慧智聚焦八大目標 搶攻癌症健檢新市場
